Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Current Medical Research and Opinion
|
July 22, 2022
Development of a claims-based flare algorithm for systemic lupus erythematosus
Iris Goetz, Casey Choong, Jennifer Winnie, et al.
Journal of Managed Care & Specialty Pharmacy
|
November 25, 2022
Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study
Kristin A Evans, Michael Pollack, Edward Portillo, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
February 18, 2022
PRIMUS - Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation
Joseph Tkacz, Kristin A Evans, Daniel R Touchette, et al.
Drugs in R&D
|
July 29, 2018
The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
Vance J Bray, Aaron Broadwell, Herbert S B Baraf, et al.
Respiratory Medicine
|
April 20, 2026
Outcomes of Patients with COPD Before and After Initiation of Treatment with Budesonide/Glycopyrrolate/Formoterol Fumarate: Results from the US ARCTOS Study
Sanjay Sethi, Laurence Gozalo, Donna McMorrow, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 30, 2020
The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis
Devin Incerti, Ervant J Maksabedian Hernandez, Joseph Tkacz, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 20, 2024
Gaps in Care Among Uncontrolled Severe Asthma Patients in the United States
Tara Carr, Joseph Tkacz, Yen Chung, et al.
Current Medical Research and Opinion
|
August 11, 2025
Prompt initiation of single-inhaler budesonide/glycopyrrolate/formoterol fumarate (BGF) following a COPD exacerbation reduces exacerbations and cardiopulmonary risk in patients with COPD: insights from the MITOS EROS+CP study in the United States
Michael Pollack, Joseph Tkacz, Jill Schinkel, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
October 18, 2023
Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
Charlie Strange, Joseph Tkacz, Jill Schinkel, et al.
Clinical Therapeutics
|
September 3, 2022
Systemic Corticosteroid-related Adverse Outcomes and Health Care Resource Utilization and Costs Among Patients with Chronic Rhinosinusitis with Nasal Polyposis
Greg E Davis, Robert S Zeiger, Benjamin Emmanuel, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Current Medical Research and Opinion
|
July 22, 2022
Development of a claims-based flare algorithm for systemic lupus erythematosus
Iris Goetz, Casey Choong, Jennifer Winnie, et al.
Journal of Managed Care & Specialty Pharmacy
|
November 25, 2022
Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study
Kristin A Evans, Michael Pollack, Edward Portillo, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
February 18, 2022
PRIMUS - Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation
Joseph Tkacz, Kristin A Evans, Daniel R Touchette, et al.
Drugs in R&D
|
July 29, 2018
The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
Vance J Bray, Aaron Broadwell, Herbert S B Baraf, et al.
Respiratory Medicine
|
April 20, 2026
Outcomes of Patients with COPD Before and After Initiation of Treatment with Budesonide/Glycopyrrolate/Formoterol Fumarate: Results from the US ARCTOS Study
Sanjay Sethi, Laurence Gozalo, Donna McMorrow, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 30, 2020
The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis
Devin Incerti, Ervant J Maksabedian Hernandez, Joseph Tkacz, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
March 20, 2024
Gaps in Care Among Uncontrolled Severe Asthma Patients in the United States
Tara Carr, Joseph Tkacz, Yen Chung, et al.
Current Medical Research and Opinion
|
August 11, 2025
Prompt initiation of single-inhaler budesonide/glycopyrrolate/formoterol fumarate (BGF) following a COPD exacerbation reduces exacerbations and cardiopulmonary risk in patients with COPD: insights from the MITOS EROS+CP study in the United States
Michael Pollack, Joseph Tkacz, Jill Schinkel, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
October 18, 2023
Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
Charlie Strange, Joseph Tkacz, Jill Schinkel, et al.
Clinical Therapeutics
|
September 3, 2022
Systemic Corticosteroid-related Adverse Outcomes and Health Care Resource Utilization and Costs Among Patients with Chronic Rhinosinusitis with Nasal Polyposis
Greg E Davis, Robert S Zeiger, Benjamin Emmanuel, et al.
Page
of 6